Based on the Getinge AB ser. B stock forecast from 0 analysts, the average analyst target price for Getinge AB ser. B is not available over the next 12 months. Getinge AB ser. B’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Getinge AB ser. B is Very Bullish, which is based on 1 positive signals and 0 negative signals. At the last closing, Getinge AB ser. B’s stock price was SEK 189.93. Getinge AB ser. B’s stock price has changed by -2.23% over the past week, -0.45% over the past month and +1.65% over the last year.
No recent analyst target price found for Getinge AB ser. B
No recent average analyst rating found for Getinge AB ser. B
Company Overview Getinge AB ser. B
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, bioreactors, bioprocess control systems, bioprocess software, biobundles, bioprocess analytics, and perfusion systems; monitoring systems, anesthesia machines, beating heart stabilizers and positioners, axius blower mister and coronary shunts, proximal seal systems, ceiling supply units, connected devices, cleaning and disinfection products, packaging and sealing solutions, monitors and indicators, and SteriTec products. The company also provides thoracic catheters, dry seal chest drain, mobile dry seal drain, dry and wet suction water seal chest drain, and chest drain valves; transitional accessories; endoscope reprocessing; endoscopic vessel harvesting systems; endovascular products; pressure controlling syringes, vessel harvesting systems, balloon expandable covered stents, tubing sets, hemoconcentrators, and lung machines; and OR integration and management. In addition, it offers extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packing products; mechanical ventilation products; medical furniture; modular room systems; operating lights and tables; patient transport; sterile supply management; sterilization; surgical assist systems; surgical perfusion; transport and storage; trays and baskets; vascular and cardiothoracic surgery solutions; sterilizer loading equipment; and cage handing systems. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden. Address: Lindholmspiren 7A, Gothenburg, Sweden, 417 56 Read Less
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing sys...Read More
Frequently Asked Questions About Getinge AB ser. B (0GZV:LSE) Stock
Stock Target Advisor's fundamental analysis for Getinge AB ser. B's stock is Very Bullish.
0GZV:LSE stock's dividend yield is 0.02%.
Based on this 0GZV:LSE may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on 0GZV:LSE's stock to indicate what its average analyst target is.
0GZV:LSE stock's Price/Earning ratio is 0.22.
Based on this 0GZV:LSE may be a overvalued for its sector.
The last closing price of 0GZV:LSE's stock was SEK 189.93.
The most recent market capitalization for 0GZV:LSE is SEK 0.62B.
Unfortunately we do not have enough analyst data on 0GZV:LSE's stock to indicate whether its price will go up or not.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
What not to like
There is nothing we particularly dislike
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 0GZV:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
